ΩνFf¨ζΡTZ~AΜβ`qff
|ΑΙLΝΝβ`qΈ^ΜΈf[Μθ|
@@K@v*@R@ι@ΐ@[*
@@@@@@@@@@@@@@@@@@@@@@
Gene Diagnosis of Hemoglobinopathies
|The Determination of Breakpoints for a Large Deletion|
Yukio HATTORI, MD* and Yasuhiro YAMASHIRO, PhD*
A large number of mutations leading to hemoglobinopathies(abnormal hemoglobins,
thalassemias) have been discovered. Gene diagnosis for a point mutation
or a deletion/insertion of a few nucleotides is now readily performed.
For a large deletion, once the precise breakpoints are unraveled, the same
type of deletion is promptly diagnosed by gap PCR. However, a number of
new types of large deletions remain unexamined. They need meticulous Southern
blot analysis and/or cloning. Here we present a new technique to determine
their precise breakpoints. One of the two breakpoints needs to be first
assigned within the 5-kb portion estimated by gene dosage by quantitative
PCR. The other breakpoint is left unexamined. The genome DNA is digested
with one of eight kinds of endonucleases and subjected to recombination
with pUC18 cloning vector digested with the same endonuclease. The gap
PCR is subsequently performed between the common primers of pUC18 and five
arbitrary primers within the aforementioned 5-kb portion. An abnormal gap
PCR product, if detected by electrophoresis, discloses precise 5f and
3f breakpoints after direct sequencing. This method successfully disclosed
the breakpoints for two ΓΑΒΐ-thalassemias, one Βΐ-thalassemia and
one ΐ-thalassmeia in a relatively short period. All are new mutations.
This method uses neither cloning procedures nor Southern blot, but employs
gene dosage estimation and PCR. Thus, it is relatively simple. The progress
of the genome project facilitated analysis of any large deletions.
[Rinsho Byori 51 : 550`555, 2003]
*Faculty of Health Sciences, Yamaguchi University School of Medicine, Ube 755-8505
yKey Wordszabnormal hemoglobin(ΩνHb)CΏ-thalassemia(ΏTZ~A)Cΐ-thalassemia(ΐTZ~A)Cgene
diagnosis(β`qff)CPCR
*RϋεwγwΫwΘaΤΈwuΐ(§755-8554 Fsμ¬ψ1-1-1)
E-mail :hattori-ygc@umin.ac.jp